JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ro, J. Y.
Right arrow Articles by Park, Y. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ro, J. Y.
Right arrow Articles by Park, Y. I.

Vol. 292, Issue 1, 114-121, January 2000

Inhibitory Mechanism of Aloe Single Component (Alprogen) on Mediator Release in Guinea Pig Lung Mast Cells Activated with Specific Antigen-Antibody Reactions1

Jai Youl Ro, Byung Chul Lee, Ji Young Kim, Yean Jun Chung, Myung Hee Chung, Seung Kee Lee, Tae Hyung Jo, Kyung Hwan Kim and Young In Park

Department of Pharmacology, Yonsei University College of Medicine (J.Y.R., J.Y.K., K.H.K.); Graduate School of Biotechnology, Korea University (B.C.L., Y.J.C., Y.I.P.); Department of Pharmacology, Seoul National University College of Medicine (M.H.C.); Department of Biochemistry, Seoul National University College of Pharmacy (S.K.L.); and Life Science Institute, Nam Yang Aloe Company (T.H.J.), Seoul, Korea

We previously reported that the glycoprotein extracted from aloe strongly inhibited the mediator releases caused by the activation of guinea pig lung mast cells. Therefore, this study aimed to purify a single component that has an antiallergic effect from crude aloe extract and then to assess the effects of aloe single component (alprogen) on the mechanism of mediator releases caused by the mast cell activation. We purified aloe extracts by using various columns. We also purified mast cells from guinea pig lung tissues by using enzyme digestion, rough and discontinuous density Percoll gradient. Mast cells were sensitized with IgG1 (anti-ovalbumin) and challenged with ovalbumin. Histamine was assayed by using a fluorometric analyzer and leukotrienes by radioimmunoassay. [Ca2+]i level was analyzed by using a confocal laser scanning microscope. Protein kinase activity was determined by the protein phosphorylated with [gamma -32P]ATP. The phospholipase D activity was assessed by the labeled phosphatidylalcohol. The amount of mass 1,2-diacylglycerol (DAG) was measured by the [3H]DAG produced when prelabeled with [3H]myristic acid. Phospholipase A2 activity was determined by measuring the lyso-phosphatidylcholine released from the labeled phospholipids. Alprogen significantly decreased histamine and leukotriene releases and blocked completely Ca2+ influx during mast cell activation. The protein kinase C and phospholipase D activities were decreased by alprogen in dose-dependent manner. Alprogen inhibited mass DAG formation and the phospholipase A2 activity during mast cell activation. The data suggest that alprogen purified from aloe inhibits multiple signals as well as blocking Ca2+ influx caused by mast cells activated with specific antigen-antibody reactions and that then the inhibition of histamine and leukotriene release follows.


1 This study was supported by the 1995-1998 STEPI (Science and Technology Policy Institute) Grant and a Nam Yang Institute Grant in Seoul, Korea.


0022-3565/0/2921-0114$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.